Sarah White, MPH, joined the MRCT Center as the Executive Director in January of 2018 and is responsible for developing, defining, and implementing the overall strategy and vision for the Center as well as oversee all management aspects of the MRCT Center functions. Sarah has almost 20 years of experience in human subjects’ research including experience at both academic medical centers and Industry and is recognized for collaboration, team building and bringing positive energy to projects. Prior to joining the MRCT Center, Sarah was the Director of the Human Research Quality Improvement Program (QI Program) at Partners’ Healthcare in Boston, Massachusetts. In this capacity, she was responsible for strategic planning and oversight of the QI Program activities across the human research communities at Partners Healthcare, including Massachusetts General Hospital and Brigham and Women’s Hospital. In addition, Sarah oversaw FDA Sponsor-Investigator support and the centralized support of clinical trials registration and disclosure. Sarah is the chair of the national Clinical Trials Registration Taskforce, a large consortium of academic medical centers, hospitals and universities that identify best practices, develop tools, and serve as a communication forum associated with the requirements for clinical trials registration and results reporting that affect US academic health centers. Sarah also co-chaired of the Harvard Catalyst Quality Assurance/Quality Improvement Subcommittee from 2010 to 2018. Sarah received her undergraduate degree from Dartmouth College and her MPH from Boston University School of Public Health.